BIVI
BioVie Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.00
−1.48%4
Insider buys (3m)
0
Insider sells (3m)
$49.1K
Net value (3m)
+27.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 28, 2026 | Palumbo Joseph M · officer: Chief Medical Officer | Purchase | 4,843 | $2.16 |
| Aug 28, 2026 | DO CUONG V · director, officer: President & CEO | Purchase | 15,210 | $2.08 |
| Aug 28, 2026 | KIM JOANNE WENDY · officer: Chief Financial Officer | Purchase | 2,500 | $2.18 |
| Aug 28, 2026 | Chappell Amy Suzon · director | Purchase | 727 | $2.16 |
| Jan 9, 2026 | Chappell Amy Suzon · director | A-Award | 57,500 | $1.31 |
| Jan 9, 2026 | Lang James Paul · director | A-Award | 330,500 | $1.31 |
| Jan 9, 2026 | Lang James Paul · director | A-Award | 90,000 | $1.31 |
| Jan 9, 2026 | Palumbo Joseph M · officer: Chief Medical Officer | A-Award | 132,000 | $1.31 |
| Jan 9, 2026 | KIM JOANNE WENDY · officer: Chief Financial Officer | A-Award | 110,100 | $1.31 |
| Jan 9, 2026 | ROGICH SIGMUND · director | A-Award | 70,000 | $1.31 |
| Jan 9, 2026 | Sherman Michael Edward · director | A-Award | 341,100 | $1.31 |
| Jan 9, 2026 | Sherman Michael Edward · director | A-Award | 80,000 | $1.31 |
| Jan 9, 2026 | Farag Kameel D. · director | A-Award | 57,500 | $1.31 |
| Jan 9, 2026 | DO CUONG V · director, officer: President & CEO | A-Award | 665,300 | $1.31 |
| Jan 9, 2026 | ROGICH SIGMUND · director | A-Award | 141,100 | $1.31 |
| Aug 13, 2025 | DO CUONG V · director, officer: President & CEO | Purchase | 5,000 | $0.00 |
| Jan 7, 2025 | DO CUONG V · director, officer: President & CEO | A-Award | 104,502 | $1.90 |
| Jan 7, 2025 | ROGICH SIGMUND · director | A-Award | 32,700 | $0.00 |
| Jan 7, 2025 | ROGICH SIGMUND · director | A-Award | 22,070 | $1.90 |
| Jan 7, 2025 | BERMAN RICHARD J · director | A-Award | 34,200 | $0.00 |
| Jan 7, 2025 | BERMAN RICHARD J · director | A-Award | 23,155 | $1.90 |
| Jan 7, 2025 | Sherman Michael Edward · director | A-Award | 56,900 | $3.36 |
| Jan 7, 2025 | Sherman Michael Edward · director | A-Award | 23,325 | $1.90 |
| Jan 7, 2025 | Lang James Paul · director | A-Award | 61,600 | $3.36 |
| Jan 7, 2025 | Lang James Paul · director | A-Award | 22,690 | $1.90 |
| Jan 7, 2025 | Hariri Robert J · director | A-Award | 49,800 | $3.36 |
| Jan 7, 2025 | Hariri Robert J · director | A-Award | 21,815 | $1.90 |
| Jan 7, 2025 | Palumbo Joseph M · officer: Chief Medical Officer | A-Award | 15,417 | $1.90 |
| Jan 7, 2025 | KIM JOANNE WENDY · officer: Chief Financial Officer | A-Award | 14,417 | $1.90 |
| Jul 12, 2024 | Palumbo Joseph M · officer: Chief Medical Officer | A-Award | 156,000 | $0.47 |
Institutional positioning
13F filings over the trailing two quarters
New 7Increased 7Reduced 6Sold out 33
| Filer | Action | Shares | Filed |
|---|---|---|---|
| DIAMETRIC CAPITAL, LP | Unchanged | 370,000 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 95,952 | Sep 2, 2026 |
| PRELUDE CAPITAL MANAGEMENT, LLC | Unchanged | 92,063 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 84,203 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 84,067 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 75,221 | May 15, 2026 |
| PHILADELPHIA TRUST CO | Unchanged | 75,010 | May 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 67,918 | May 14, 2026 |
| CITADEL ADVISORS LLC | Increased | 45,292 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 37,557 | May 8, 2026 |
| HRT FINANCIAL LP | New Position | 23,482 | May 14, 2026 |
| JANE STREET GROUP, LLC | Increased | 22,791 | May 12, 2026 |
| XTX TOPCO LTD | Reduced | 21,226 | May 15, 2026 |
| NORTHERN TRUST CORP | Unchanged | 14,189 | May 14, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Increased | 7,540 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 28, 2026